LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 71

Search options

  1. Article ; Online: Author Correction: Protein-based profiling of the human IgA1 clonal repertoire revealed shared clones of serum polymeric IgA1 and milk secretory IgA1.

    Novak, Jan / Renfrow, Matthew B / King, R Glenn / Reily, Colin / Green, Todd J

    Cellular & molecular immunology

    2024  Volume 20, Issue 3, Page(s) 310

    Language English
    Publishing date 2024-02-21
    Publishing country China
    Document type Published Erratum
    ZDB-ID 2435097-7
    ISSN 2042-0226 ; 1672-7681
    ISSN (online) 2042-0226
    ISSN 1672-7681
    DOI 10.1038/s41423-023-00977-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: GDP polyribonucleotidyltransferase domain of vesicular stomatitis virus polymerase regulates leader-promoter escape and polyadenylation-coupled termination during stop-start transcription.

    Ogino, Minako / Green, Todd J / Ogino, Tomoaki

    PLoS pathogens

    2022  Volume 18, Issue 2, Page(s) e1010287

    Abstract: The unconventional mRNA capping enzyme (GDP polyribonucleotidyltransferase, PRNTase) domain of the vesicular stomatitis virus (VSV) L protein possesses a dual-functional "priming-capping loop" that governs terminal de novo initiation for leader RNA ... ...

    Abstract The unconventional mRNA capping enzyme (GDP polyribonucleotidyltransferase, PRNTase) domain of the vesicular stomatitis virus (VSV) L protein possesses a dual-functional "priming-capping loop" that governs terminal de novo initiation for leader RNA synthesis and capping of monocistronic mRNAs during the unique stop-start transcription cycle. Here, we investigated the roles of basic amino acid residues on a helix structure directly connected to the priming-capping loop in viral RNA synthesis and identified single point mutations that cause previously unreported defective phenotypes at different steps of stop-start transcription. Mutations of residue R1183 (R1183A and R1183K) dramatically reduced the leader RNA synthesis activity by hampering early elongation, but not terminal de novo initiation or productive elongation, suggesting that the mutations negatively affect escape from the leader promoter. On the other hand, mutations of residue R1178 (R1178A and R1178K) decreased the efficiency of polyadenylation-coupled termination of mRNA synthesis at the gene junctions, but not termination of leader RNA synthesis at the leader-to-N-gene junction, resulting in the generation of larger amounts of aberrant polycistronic mRNAs. In contrast, both the R1183 and R1178 residues are not essential for cap-forming activities. The R1183K mutation was lethal to VSV, whereas the R1178K mutation attenuated VSV and triggered the production of the polycistronic mRNAs in infected cells. These observations suggest that the PRNTase domain plays multiple roles in conducting accurate stop-start transcription beyond its known role in pre-mRNA capping.
    MeSH term(s) Amino Acid Substitution ; Animals ; Cell Line ; DNA-Directed RNA Polymerases/genetics ; DNA-Directed RNA Polymerases/metabolism ; Mutation ; Nucleotidyltransferases/metabolism ; Polyribonucleotide Nucleotidyltransferase/genetics ; Polyribonucleotide Nucleotidyltransferase/metabolism ; Protein Conformation ; Protein Domains ; RNA Precursors/metabolism ; RNA, Viral/metabolism ; RNA-Dependent RNA Polymerase/genetics ; RNA-Dependent RNA Polymerase/metabolism ; Transcription, Genetic ; Vesicular Stomatitis/virology ; Vesicular stomatitis Indiana virus/genetics ; Vesicular stomatitis Indiana virus/metabolism ; Viral Proteins/genetics ; Viral Proteins/metabolism ; Virus Replication
    Chemical Substances RNA Precursors ; RNA, Viral ; Viral Proteins ; Nucleotidyltransferases (EC 2.7.7.-) ; L protein, vesicular stomatitis virus (EC 2.7.7.48) ; RNA-Dependent RNA Polymerase (EC 2.7.7.48) ; mRNA guanylyltransferase (EC 2.7.7.50) ; DNA-Directed RNA Polymerases (EC 2.7.7.6) ; Polyribonucleotide Nucleotidyltransferase (EC 2.7.7.8)
    Language English
    Publishing date 2022-02-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7374
    ISSN (online) 1553-7374
    ISSN 1553-7374
    DOI 10.1371/journal.ppat.1010287
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Atomic view of the HIV-1 matrix lattice; implications on virus assembly and envelope incorporation.

    Samal, Alexandra B / Green, Todd J / Saad, Jamil S

    Proceedings of the National Academy of Sciences of the United States of America

    2022  Volume 119, Issue 23, Page(s) e2200794119

    Abstract: During the late phase of HIV type 1 (HIV-1) infection cycle, the virally encoded Gag polyproteins are targeted to the inner leaflet of the plasma membrane (PM) for assembly, formation of immature particles, and virus release. Gag binding to the PM is ... ...

    Abstract During the late phase of HIV type 1 (HIV-1) infection cycle, the virally encoded Gag polyproteins are targeted to the inner leaflet of the plasma membrane (PM) for assembly, formation of immature particles, and virus release. Gag binding to the PM is mediated by interactions of the N-terminally myristoylated matrix (myrMA) domain with phosphatidylinositol 4,5-bisphosphate. Formation of a myrMA lattice on the PM is an obligatory step for the assembly of immature HIV-1 particles and envelope (Env) incorporation. Atomic details of the myrMA lattice and how it mediates Env incorporation are lacking. Herein, we present the X-ray structure of myrMA at 2.15 Å. The myrMA lattice is arranged as a hexamer of trimers with a central hole, thought to accommodate the C-terminal tail of Env to promote incorporation into virions. The trimer–trimer interactions in the lattice are mediated by the N-terminal loop of one myrMA molecule and α-helices I–II, as well as the 310 helix of a myrMA molecule from an adjacent trimer. We provide evidence that substitution of MA residues Leu13 and Leu31, previously shown to have adverse effects on Env incorporation, induced a conformational change in myrMA, which may destabilize the trimer–trimer interactions within the lattice. We also show that PI(4,5)P2 is capable of binding to alternating sites on MA, consistent with an MA–membrane binding mechanism during assembly of the immature particle and upon maturation. Altogether, these findings advance our understanding of a key mechanism in HIV-1 particle assembly.
    MeSH term(s) Cell Membrane/metabolism ; HIV-1/metabolism ; Protein Domains ; Virion/metabolism ; Virus Assembly ; gag Gene Products, Human Immunodeficiency Virus/metabolism
    Chemical Substances gag Gene Products, Human Immunodeficiency Virus
    Language English
    Publishing date 2022-06-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2200794119
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: RNA Synthesis and Capping by Non-segmented Negative Strand RNA Viral Polymerases: Lessons From a Prototypic Virus.

    Ogino, Tomoaki / Green, Todd J

    Frontiers in microbiology

    2019  Volume 10, Page(s) 1490

    Abstract: Non-segmented negative strand (NNS) RNA viruses belonging to the ... ...

    Abstract Non-segmented negative strand (NNS) RNA viruses belonging to the order
    Language English
    Publishing date 2019-07-10
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2587354-4
    ISSN 1664-302X
    ISSN 1664-302X
    DOI 10.3389/fmicb.2019.01490
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Transcriptional Control and mRNA Capping by the GDP Polyribonucleotidyltransferase Domain of the Rabies Virus Large Protein.

    Ogino, Tomoaki / Green, Todd J

    Viruses

    2019  Volume 11, Issue 6

    Abstract: Rabies virus (RABV) is a causative agent of a fatal neurological disease in humans and animals. The large (L) protein of RABV is a multifunctional RNA-dependent RNA polymerase, which is one of the most attractive targets for developing antiviral agents. ... ...

    Abstract Rabies virus (RABV) is a causative agent of a fatal neurological disease in humans and animals. The large (L) protein of RABV is a multifunctional RNA-dependent RNA polymerase, which is one of the most attractive targets for developing antiviral agents. A remarkable homology of the RABV L protein to a counterpart in vesicular stomatitis virus, a well-characterized rhabdovirus, suggests that it catalyzes mRNA processing reactions, such as 5'-capping, cap methylation, and 3'-polyadenylation, in addition to RNA synthesis. Recent breakthroughs in developing in vitro RNA synthesis and capping systems with a recombinant form of the RABV L protein have led to significant progress in our understanding of the molecular mechanisms of RABV RNA biogenesis. This review summarizes functions of RABV replication proteins in transcription and replication, and highlights new insights into roles of an unconventional mRNA capping enzyme, namely GDP polyribonucleotidyltransferase, domain of the RABV L protein in mRNA capping and transcription initiation.
    MeSH term(s) Animals ; DNA-Directed RNA Polymerases/genetics ; DNA-Directed RNA Polymerases/metabolism ; Gene Expression Regulation ; Genome, Viral ; Humans ; Polyribonucleotide Nucleotidyltransferase/genetics ; Polyribonucleotide Nucleotidyltransferase/metabolism ; RNA Caps/metabolism ; RNA, Viral/genetics ; RNA, Viral/metabolism ; Rabies virus/chemistry ; Rabies virus/genetics ; Rabies virus/metabolism ; Rhabdoviridae/genetics ; Rhabdoviridae/metabolism ; Transcription, Genetic ; Viral Proteins/genetics ; Viral Proteins/metabolism ; Virus Replication
    Chemical Substances RNA Caps ; RNA, Viral ; Viral Proteins ; L protein, Rabies virus (EC 2.7.7.48) ; DNA-Directed RNA Polymerases (EC 2.7.7.6) ; Polyribonucleotide Nucleotidyltransferase (EC 2.7.7.8)
    Language English
    Publishing date 2019-06-01
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v11060504
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Discontinuous L-binding motifs in the transactivation domain of the vesicular stomatitis virus P protein are required for terminal

    Gupta, Nirmala / Ogino, Minako / Watkins, Dean E / Yu, Tiffany / Green, Todd J / Ogino, Tomoaki

    Journal of virology

    2023  Volume 97, Issue 8, Page(s) e0024623

    Abstract: The phospho- (P) protein, the co-factor of the RNA polymerase large (L) protein, of vesicular stomatitis virus (VSV, a prototype of nonsegmented negative-strand RNA viruses) plays pivotal roles in transcription and replication. However, the precise ... ...

    Abstract The phospho- (P) protein, the co-factor of the RNA polymerase large (L) protein, of vesicular stomatitis virus (VSV, a prototype of nonsegmented negative-strand RNA viruses) plays pivotal roles in transcription and replication. However, the precise mechanism underlying the transcriptional transactivation by the P protein has remained elusive. Here, using an
    MeSH term(s) Animals ; Vesicular Stomatitis/genetics ; Transcriptional Activation ; RNA, Viral/genetics ; RNA, Viral/metabolism ; Vesiculovirus/metabolism ; Vesicular stomatitis Indiana virus/genetics ; Vesicular stomatitis Indiana virus/metabolism ; RNA, Messenger/genetics ; Amino Acids/genetics ; Transcription, Genetic ; Virus Replication/genetics
    Chemical Substances RNA, Viral ; RNA, Messenger ; Amino Acids
    Language English
    Publishing date 2023-08-14
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/jvi.00246-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Structure of Nonstructural Protein 1 from SARS-CoV-2.

    Clark, Lauren K / Green, Todd J / Petit, Chad M

    Journal of virology

    2021  Volume 95, Issue 4

    Abstract: The periodic emergence of novel coronaviruses (CoVs) represents an ongoing public health concern with significant health and financial burdens worldwide. The most recent occurrence originated in the city of Wuhan, China, where a novel coronavirus (severe ...

    Abstract The periodic emergence of novel coronaviruses (CoVs) represents an ongoing public health concern with significant health and financial burdens worldwide. The most recent occurrence originated in the city of Wuhan, China, where a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) emerged causing severe respiratory illness and pneumonia. The continual emergence of novel coronaviruses underscores the importance of developing effective vaccines as well as novel therapeutic options that target either viral functions or host factors recruited to support coronavirus replication. The CoV nonstructural protein 1 (nsp1) has been shown to promote cellular mRNA degradation, block host cell translation, and inhibit the innate immune response to virus infection. Interestingly, deletion of the nsp1-coding region in infectious clones prevented the virus from productively infecting cultured cells. Because of nsp1's importance in the CoV life cycle, it has been highlighted as a viable target for both antiviral therapy and vaccine development. However, the fundamental molecular and structural mechanisms that underlie nsp1 function remain poorly understood, despite its critical role in the viral life cycle. Here, we report the high-resolution crystal structure of the amino globular portion of SARS-CoV-2 nsp1 (residues 10 to 127) at 1.77-Å resolution. A comparison of our structure with the SARS-CoV-1 nsp1 structure reveals how mutations alter the conformation of flexible loops, inducing the formation of novel secondary structural elements and new surface features. Paired with the recently published structure of the carboxyl end of nsp1 (residues 148 to 180), our results provide the groundwork for future studies focusing on SARS-CoV-2 nsp1 structure and function during the viral life cycle.
    MeSH term(s) Amino Acid Sequence ; COVID-19/virology ; Cell Line ; Crystallography, X-Ray ; Humans ; Protein Conformation ; SARS-CoV-2/chemistry ; SARS-CoV-2/genetics ; Sequence Alignment ; Viral Nonstructural Proteins/chemistry ; Viral Nonstructural Proteins/metabolism
    Chemical Substances NSP1 protein, SARS-CoV-2 ; Viral Nonstructural Proteins
    Language English
    Publishing date 2021-01-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/JVI.02019-20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Neutrophil elastase-dependent cleavage of LTA4H alters its aminopeptidase activity in cystic fibrosis.

    Xu, Xin / Li, Jin-Dong / Green, Todd J / Wilson, Landon / Genschmer, Kristopher / Russell, Derek / Blalock, J Edwin / Gaggar, Amit

    The European respiratory journal

    2024  Volume 63, Issue 3

    MeSH term(s) Humans ; Leukocyte Elastase ; Cystic Fibrosis ; Proteolysis ; Aminopeptidases/genetics ; Neutrophils
    Chemical Substances Leukocyte Elastase (EC 3.4.21.37) ; Aminopeptidases (EC 3.4.11.-)
    Language English
    Publishing date 2024-03-07
    Publishing country England
    Document type Letter
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.01512-2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.

    Rajasekaran, Arun / Green, Todd J / Renfrow, Matthew B / Julian, Bruce A / Novak, Jan / Rizk, Dana V

    Drugs

    2023  Volume 83, Issue 16, Page(s) 1475–1499

    Abstract: Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and a frequent cause of kidney failure. Currently, the diagnosis necessitates a kidney biopsy, with routine immunofluorescence microscopy revealing IgA as the ... ...

    Abstract Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and a frequent cause of kidney failure. Currently, the diagnosis necessitates a kidney biopsy, with routine immunofluorescence microscopy revealing IgA as the dominant or co-dominant immunoglobulin in the glomerular immuno-deposits, often with IgG and sometimes IgM or both. Complement protein C3 is observed in most cases. IgAN leads to kidney failure in 20-40% of patients within 20 years of diagnosis and reduces average life expectancy by about 10 years. There is increasing clinical, biochemical, and genetic evidence that the complement system plays a paramount role in the pathogenesis of IgAN. The presence of C3 in the kidney immuno-deposits differentiates the diagnosis of IgAN from subclinical glomerular mesangial IgA deposition. Markers of complement activation via the lectin and alternative pathways in kidney-biopsy specimens are associated with disease activity and are predictive of poor outcome. Levels of select complement proteins in the circulation have also been assessed in patients with IgAN and found to be of prognostic value. Ongoing genetic studies have identified at least 30 loci associated with IgAN. Genes within some of these loci encode complement-system regulating proteins that can interact with immune complexes. The growing appreciation for the central role of complement components in IgAN pathogenesis highlighted these pathways as potential treatment targets and sparked great interest in pharmacological agents targeting the complement cascade for the treatment of IgAN, as evidenced by the plethora of ongoing clinical trials.
    MeSH term(s) Humans ; Glomerulonephritis, IGA/drug therapy ; Kidney ; Complement C3 ; Immunoglobulin A ; Renal Insufficiency
    Chemical Substances Complement C3 ; Immunoglobulin A
    Language English
    Publishing date 2023-09-25
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-023-01940-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Protein-based profiling of the human IgA1 clonal repertoire revealed shared clones of serum polymeric IgA1 and milk secretory IgA1.

    Novak, Jan / Renfrow, Matthew B / King, R Glenn / Reily, Colin / Green, Todd J

    Cellular & molecular immunology

    2023  Volume 20, Issue 3, Page(s) 305–307

    MeSH term(s) Animals ; Humans ; Clone Cells ; Immunoglobulin A ; Immunoglobulin A, Secretory ; Milk
    Chemical Substances Immunoglobulin A ; Immunoglobulin A, Secretory
    Language English
    Publishing date 2023-01-04
    Publishing country China
    Document type Research Support, N.I.H., Extramural ; Journal Article ; Comment
    ZDB-ID 2435097-7
    ISSN 2042-0226 ; 1672-7681
    ISSN (online) 2042-0226
    ISSN 1672-7681
    DOI 10.1038/s41423-022-00965-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top